Showing results (1021-1030 of 2,181) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|September 7, 2023
Bayesian hierarchical model for dose-finding trial incorporating historical dataLinxi Han, Qiqi Deng, Zhangyi He, et al.Journal of Biopharmaceutical Statistics|March 6, 2026
Randomized trials with composite time-to-event outcomes: Is the win ratio approach always the best?Jingyi Lin, Ludovic TrinquartJournal of Biopharmaceutical Statistics|February 24, 2026
Balancing the effective sample size in prior across different doses in the curve-free Bayesian decision-theoretic design for dose-finding trialsJiapeng Xu, Dehua Bi, Shenghua Kelly Fan, et al.Journal of Biopharmaceutical Statistics|February 23, 2026
BLRM-EffTox: A seamless two-stage phase 1 Bayesian logistic regression design incorporating efficacy-toxicity trade-off for dose optimizationXin Liu, Cynthia Basu, Arnab Kumar Maity, et al.Journal of Biopharmaceutical Statistics|April 2, 2026
Dynamic borrowing methods for basket trials with order restrictionsLauren Kanapka, Anastasia IvanovaJournal of Biopharmaceutical Statistics|April 14, 2026
Enhanced doubly robust estimation in clinical trials accounting for intercurrent eventsJunyi Zhang, Ao Yuan, Chenguang Wang, et al.Journal of Biopharmaceutical Statistics|May 20, 2026
Statistical approaches to classify investigational product using hERG safety assayYu-Ting Weng, Dalong HuangJournal of Biopharmaceutical Statistics|May 19, 2026
AI-powered digital innovations in pharmaceuticals research & development: Current landscape and case examplesXiao Li, Jian Dai, Herbert PangJournal of Biopharmaceutical Statistics|April 27, 2026
Multivariate equivalence and component-wise superiority tests for paired samplesYanxi Hu, Vernon M ChinchilliJournal of Biopharmaceutical Statistics|May 13, 2026
Impacts of reducing the number of hERG assay concentration levels on IC50 estimationYu-Ting Weng, Dalong HuangPageof 219